The Center for Advancing Innovation Announces Collaboration with Johnson & Johnson Innovation, JLABS
BETHESDA, Md. (PRWEB) March 22, 2018 -- The Center for Advancing Innovation (CAI), the world’s largest virtual startup challenge-based accelerator, announced today a collaboration with Johnson & Johnson Innovation, JLABS to provide at least one startup from CAI’s Freedom from Cancer Startup Challenge lab and/or office space at JLABS @ TMC in Houston.
CAI, also coined the “Tinder for Startups” by Nature is a 501c3 with a mission to advance promising inventions that will impact the world. CAI’s Freedom from Cancer Startup Challenge initiative has an audacious goal to launch 100 companies focused on treating and diagnosing cancer. The breakthrough inventions in the challenge came from more than a fifty leading universities, hospitals and federal agencies. Teams of entrepreneurs are competing to form startup companies around 117 breakthrough inventions from 55 institutions, including the National Institutes of Health (National Cancer Institute, National Heart, Lung, and Blood Institute, and National Institute of Biomedical Imaging and Bioengineering), the United States Army, and more than fifty American universities and hospitals.
“Startups need a galvanized, robust entrepreneurial ecosystem and platform to launch and grow. JLABS @ TMC in Houston offers a rich research, academic, and investment community,” said Rosemarie Truman, CAI’s Founder and CEO.
About the Center for Advancing Innovation
The Center for Advancing Innovation (CAI) is a global public-private partnership, non-profit focused on creating a virtuous circle of innovation and driving growth breakthroughs through novel, creative paradigms and models. CAI's mission is to accelerate and increase the volume of research commercialization in support of high growth business to ignite entrepreneurship, bolster the global economy, and maximize the commercial and knowledge-based potential of promising inventions. CAI's award-winning challenge-based accelerator, rigorous evidence-based due diligence, and capital-efficient lean management models serve to hyper-accelerate "gazelle" high-performing startups for outsized investor returns. Through its NIH-sponsored Breast Cancer Startup Challenge, Neuro Startup Challenge, and Nanotechnology Startup Challenge in Cancer competitions, as well as its NASA-supported SPACE RACE startup challenge, CAI has launched 58 startups and trained more than 2000 entrepreneurs. For additional information about CAI, visit The Center for Advancing Innovation (CAI).
Rosemarie Truman, The Center for Advancing Innovation, http://www.thecenterforadvancinginnovation.org, +1 210-485-9613, [email protected]
Share this article